Background. Vitamin A supplementation reduces child mortality. It is estimated that 500 million vitamin A capsules are distributed annually. Policy recommendations have assumed that the supplementation programs offer a proven technology at a relatively low cost of around US$0.10 per capsule.
Introduction
Worldwide, between 100 and 140 million children between the ages of 6 and 59 months have vitamin A deficiency, which contributes both to blindness and to poor immune function, which in turn increases the severity of diarrhea and measles [1] [2] [3] [4] . Every year 1.2 to 3.0 million children die from the effects of vitamin A deficiency [5] . Reducing vitamin A deficiency would greatly contribute to achieving Millennium Development Goal Four, "Reduction in child mortality, " and its target of reducing by two-thirds the mortality rate among children under 5 years of age.
The problem of vitamin A deficiency in developing countries is inextricably linked to poverty. Low incomes constrain families' abilities to purchase the diverse foods they need for a nutritious and balanced diet with adequate amounts of vitamin A. Maternal vitamin A deficiency results in low concentrations of vitamin A in breastmilk, predisposing infants to deficiency. This is exacerbated by an inadequate dietary intake of vitamin A during the complementary feeding period. Finally, illness can worsen vitamin A status because of a reduced food intake from anorexia, malabsorption, and increased excretion in urine [6] .
To redress vitamin A deficiency, megadose vitamin A capsules are administered twice yearly to preschool children in many developing countries, often in conjunction with the Expanded Program of Immunization (EPI). As noted by UNICEF: The impact of vitamin A supplementation on reducing child mortality is comparable to-if not greater than-that of any single immunization against a childhood disease. Long known as a cause of blindness, vitamin A deficiency (VAD) has increasingly been recognized over the past decade as significantly heightening children's risk of dying from such common diseases as measles and diarrhea. [3] There is, however, relatively limited evidence on the costs of vitamin A capsule supplementation programs and their coverage and effectiveness [7] . Policy recommendations to date have assumed that vitamin A supplementation programs offered a proven technology at relatively low cost, which has been based on an estimate (see, for example, Levin et al. [8] ) of US$0.10 per capsule in the World Development Report Investing in Health [9] . This figure was based on the findings of three studies: a 1978 study in Haiti [10] , with a reported cost of US$0.13 per capsule delivered, and 1975 studies in Indonesia and the Philippines, both reporting costs of US$0.10 per capsule [11] . The cost estimates derived from these three studies are discussed briefly in Appendix 1. Applying a 3% annual inflation factor to this estimate of US$0.10 (in 1978 prices) gives a cost of US$0.25 per capsule delivered expressed in 2004 prices, or US$0.50 per child for two capsules per year.
The present study updates these estimates by reviewing detailed country-level cost studies on vitamin A capsule supplementation programs in seven countries, and provides a comparative analysis of the key factors that affect program costs. A full understanding of program costs is crucial for both effective policymaking and efficient allocation of resources.
Our analysis shows that the costs of vitamin A capsule supplementation programs are determined primarily by labor costs incurred in the distribution of the capsules, which account for approximately 70% of total costs. The cost of the capsules themselves, which is 2 to 4 US cents (US$0.02 to 0.04) per capsule [12] , represents only 5% of total program costs. The remaining 25% of costs are associated with promotional campaigns, training, and other expenses. Using the higher program costs documented in this paper, we estimate that the average global cost of distributing each capsule is approximately US$1, a figure four times that commonly used, although this average varies widely by region. In general, costs are lowest in low-income Africa and highest in Latin America.
Methods
To supplement and update previous findings, a search was conducted of PubMed, Cab-abstracts, and the Library of Congress for additional studies of the costs of vitamin A capsule programs. Unpublished reports were also solicited from donors and programs working on micronutrient interventions. Only two detailed cost studies, for Nepal [13] and the Philippines [14] , were found in the published literature. In addition to these two published studies, six unpublished studies were also included. Additional details are provided in Appendix 2.
Among these eight studies, detailed ex post cost analyses were available for five countries: , 1998, unpublished) included sufficiently in-depth and comprehensive data that could also be used.
Since this paper was written, another study focusing on Tanzania has been completed [15] . This study is, however, not included in the present analysis. Also, PATH Canada is attempting to collect more comprehensive and up-to-date information on costs of vitamin A interventions, including supplementation, using annual project accounts and questionnaires [16] .
To compare costs across studies, outlays in local currency were converted into US dollars for the year in which the study was conducted. The exchange rate was taken from the World Development Indicators 2004, and costs were converted to 2004 US dollars by using the inflation adjustment factors published by the US Bureau of Labor Statistics.
To examine the studies according to type of cost, five broad cost categories were identified: » Capsules (includes the cost of transporting the capsules). » Training (includes the cost of initial training and refresher costs, but excludes labor). » Promotion (includes radio and television advertisements, advertisements in cinemas, pamphlet distribution, audio cassettes played at village gatherings, and posting of signs, but excludes labor). » Personnel (includes costs of field staff and the opportunity cost of the time of volunteers). Labor costs were divided into three components: (1) the cost of permanent and shared government staff who worked year-round and who dedicated time to plan, organize, and implement the vitamin A capsule program;
(2) the cost of temporary paid labor hired for program-specific tasks (this included drivers, trainers, enumerators, communications specialists, monitors, and supervisors); and (3) an imputed cost of unpaid volunteer labor. Labor costs for additional workers hired to support the activities of full-time staff were classified as "program-specific" costs under component (2) and included activities such as technical assistance, awareness creation and social mobilization, national-level planning, and implementation.
To impute a value of unpaid volunteer labor under component (3) , an estimate of the number of days worked by volunteer per year was obtained; this was multiplied by a country-specific minimum wage rate to provide an economic value for their time.
Under component (1), the number of days worked by full-time government workers exclusively on the vitamin A capsule program was multiplied by their daily salary rate equivalent to obtain the salary cost. Other personnel costs include salaries of administrative personnel and of staff responsible for promotional and educational campaigns. For the Philippines, we excluded the time spent on follow-up after the campaign from cost calculations to ensure comparability across studies. » Other (includes expenses that do not fall explicitly into any of the other four categories: for example, vehicles, buildings, computers, paper, and other office expenses). As will be shown, the cost of vitamin A capsule programs is largely a function of the expense of labor employed to distribute the capsules. Salaries and wage rates, in turn, are closely linked to per capita income [17] . These two relationships suggest that a simple model may be used to estimate the relationship between the cost of capsule distribution and per capita income, whereby the costs of vitamin A capsule adjusted to 2004 values are regressed on per capita incomes, using a semilogarithmic formulation. Data on per capita incomes were obtained from the World Development Indicators database [18] .
Although wage rates would be a more appropriate variable to use as a proxy for labor costs than per capita income, data for several of the countries included in this study are not available in the international wage rate database developed by the International Labor Organization (ILO). Freeman et al. [17] , using the ILO database of available countries, showed a strong correlation between wages and per capita income in all countries. They argued that "the principal forces that affect the occupational wage structure around the world are the level of gross domestic product per capita and unionization/wage-setting institutions" and recommended using per capita income as a proxy where wage rate data were not available. This is the approach taken here, although it should be noted that we are unable to capture the differential rates of change of wages of the three components of labor over time.
Results

Total costs and their distribution
The results of the cost studies for the seven countries are summarized in table 1, while table 2 provides a disaggregation of these costs by the categories delineated above. The total cost per capsule delivered is lowest in Ghana (US$0.51) and Zambia (US$0.61) and highest in higher-income countries such as South Africa (US$2.27) and Peru (US$2.22). In general, costs are lower in Africa (except South Africa) than in Latin America.
The cost of the vitamin A capsule itself is low, representing an average of 4% of the total cost for all seven countries. The capsules cost US$0.02 each, and transportation costs to deliver the capsules to port range from US$0.02 to US$0.04, for an estimated cost of US$0.04 per capsule [19] . The estimated annual cost for buying and transporting the vitamin A capsules is thus relatively small-20 million dollars per year (4 cents × 500 million children per year) for the entire developing world.
Training activities averaged about 5% of total costs, but were somewhat higher in Nepal and Peru. Promotional costs averaged 12% of total costs, with higher than average costs in Nepal, the Philippines, and South Africa. For example, in Nepal, more than 25,000 leaflets are printed for each vitamin A capsule distribution campaign. International agencies sometimes support the development and broadcasting of vitamin A campaign radio spots, some of which are broadcast on radio channels with subnational (i.e., regional) coverage.
Personnel costs account for the lion's share of all costs; in all cases, field staff account for more than one-half of total costs, including the opportunity cost of the time of volunteers. Because 70% of the costs associated with distributing vitamin A capsules are related to personnel costs, countries with low wage rates and per capita incomes (e.g., Nepal) have lower costs than those with higher wage rates and per capita incomes (e.g., South Africa). Given the large share of personnel or labor costs, it is useful to examine its composition in greater detail ( table 3) .
The contribution of volunteer labor ranges from 20% of total costs in Ghana to 30% in Nepal. Volunteers account for 82% to 95% of the total number of workers, whereas the number of days worked per year per volunteer varies from 7 to 14. Even though paid labor represents only 10% of the total number of workers involved in capsule distribution, paid labor costs range from 20% to 40% of total program costs.
Factors affecting costs
Costs of integrated versus stand-alone programs
Total vitamin A capsule program costs are higher for stand-alone programs than those integrated with or "piggy-backed" on other health interventions such as National Immunization Days; for the latter, fixed costs, including personnel costs, can be shared between the two activities. Table 4 presents the data from the Philippines study, which is the only study that directly compared the costs of stand-alone and piggy-backed programs.
In Ghana, Guatemala, and Nepal, the cost studies were based on twice-yearly stand-alone campaigns. In Zambia, the vitamin A capsule distribution program was integrated into two Child Health Weeks. The Peru and South Africa feasibility studies provided costs for both stand-alone and combined programs.
Rural versus urban costs
The difference between costs in rural versus urban areas is analyzed in the Philippines and Peru cost studies. The Philippines report estimates that the cost in rural areas (US$3.16 per capsule) is 3.7 times more than in urban areas (US$0.85 per capsule). More workers and more time are needed to reach dispersed rural populations. In Peru the differences were not as sharp as in the Philippines but were still important. For example, the cost per child in metropolitan Lima was $3.33, as compared with US$3.85 for the relatively less accessible jungle areas.
Direct financial outlays
The foregoing analysis has used estimates of "economic" costs, which are higher than "financial" costs or the direct expenditures that developing country governments incur. The lower the financial costs, the more likely it is that programs will be sustained. Because permanent government employees are paid on an annual basis and unpaid volunteers do not receive a Capsule  4  10  5  2  2  4  4  4  Training  4  2  10  12  2  1  5  5  Promotion  10  2  17  5  18  22  7  12  Personnel  67  80  60  76  71  68  65  70  Other  15  6  8  5  7  5 19 9 a. Guatemala, South Africa, and Peru were excluded because the studies did not mention the use of volunteer labor, which is assumed to be zero. salary per se, these two categories are not included in the direct financial costs incurred by the governments under "program-specific" costs. Shared capital costs are also excluded. Direct financial outlays are described as "program-specific costs" in the studies and refer to costs incurred at the margin for items such as capsules; supplies; transportation; information, education, and communication; and hiring of temporary labor. In Zambia, 39% of total costs are considered program specific. The figure is 28% for Ghana.
International funding
International funding can be crucial in sustaining vitamin A capsule supplementation programs. Table 5 shows that international funding as a percentage of total financial costs varies widely, from 10% in the Philippines to 95% in the Guatemala pilot program. International organizations play a vital role in both supplying vitamin A capsules and funding program components. Some large programs, such as that in Nepal, are heavily dependent on international funding. Figure 1 shows the results of the regression relating costs of vitamin A capsules to per capita incomes. As per capita income increases, there is an increase in the cost of distributing supplements. As outlined in the note at the bottom of figure 1, the regression line provides approximate estimates for the costs of capsule distribution across regions: US$0.50 per capsule in low-income Africa, US$1 in Asia, and $US1.50 in Latin America. This result is consistent with the preliminary findings from the PATH Canada study for countries such as Uganda. For some countries the cost per capsule can be as high as US$3.50 [16] .
Estimating costs for countries worldwide
Discussion
The cost per vitamin A capsule delivered ranges from US$0.45 to US$2.25 in the seven countries analyzed. The global per-capsule cost in low-income countries was estimated to be approximately US$1, expressed in 2004 prices, and is comparable to that estimated by Helen Keller International for Africa [20] . Also, although our analysis included a relatively small The cost of manufacturing and international shipment is only US$0.02 to US$0.04 per capsule; this represents less than 5% of the total costs. Approximately 70% of the total costs are related to labor for delivering the capsules to the target population. The remaining 25% of the costs are associated with administration, marketing, planning, organization, and training.
It may cost up to twice as much to deliver capsules to rural communities than to urban ones because of the greater time and transportation costs associated with delivery to dispersed rural populations. Stand-alone campaigns also cost significantly more than those integrated with National Immunization Days-twice as much in the one study (from the Philippines) that provided comparative estimates. International funding apparently plays a critical role in financing the vitamin A supplementation programs included in this analysis.
Both the data compared in these studies and the conclusions drawn from them must be treated with caution, and further research is warranted. First, different methods were used to tabulate costs in each of the studies, and the classification of costs into specific categories was subject to various interpretations. There is a need for standardization of cost categories, as PATH Canada is attempting to do by looking at as many as 25 micronutrient intervention projects. A template has been provided by the World Health Organization (WHO) that provides a standard listing of cost categories involved in any program [21] . Further, the issue of scale has not been addressed in this paper because of insufficient information. There are considerable differences between implementing pilot programs such as the one in Guatemala, with a target population of less than 40,000, and national programs such as that in the Philippines, where more than 3 million children received capsules. Finally, the greater cost of distributing capsules to widely dispersed rural populations is also not discussed in detail here, since data on comparative costs between urban and rural areas were available for only two case studies.
This paper contributes to the larger effort required to control vitamin A deficiency by demonstrating how highly diverse estimates of the per capsule costs of delivering vitamin A capsules can be explained by differences in labor costs and wage rates across countries. Vitamin A capsule distribution is a proven intervention that continues to save lives. Even though the costs estimated in this study are higher than those previously quoted, the benefit-cost ratios remain high. If costs are subject to inflation when cost estimates are updated, so also are estimates of benefits. Public health can be improved by an expansion of vitamin A capsule programs. Nevertheless, there is a continuing need to evaluate the comparative costs of various micronutrient strategies. Reducing micronutrient malnutrition is key to meeting specific Millennium Development Goals. It is very likely that target levels for future reductions in micronutrient malnutrition-and so also the Millennium Development Goals-will not be met without a significant increase in funding for micronutrient interventions. Securing the additional funding will require not only a thorough review and update of the comparative costs of supplementation, fortification, biofortification, nutrition education, and other public health interventions, but also an analysis of how the comparative advantages of these interventions can be exploited and programs coordinated. If supplements are more expensive to deliver in less densely populated rural areas, then strategies such as delivering biofortified crops that originate in rural areas may be highly complementary.
Estimates of the cost of vitamin A capsule supplementation presented by the World Bank [9] were based on two literature reviews, one conducted by Austin et al. [10] and the second by West and Sommer [11] as outlined in the table to the right. Because these studies did not contain the level of detail required for this paper, they were not included in the comparisons.
West and Sommer [11] cite studies from Indonesia and the Philippines from 1975. The studies were commissioned to evaluate the effectiveness and coverage of vitamin A capsule programs. In both studies, the cost data are sparse and do not include distribution costs. The reported costs were US$0.10 per capsule for both countries, including the costs of the capsule and those related to transportation but not the capital costs or costs for volunteer labor and personnel.
The review by Austin et al. [10] discussed a study commissioned by Helen Keller International in Haiti in 1978, which was a detailed coverage study that did not include distribution costs. The costs ranged from US$0.13 to US$0.19, depending on the location of the community where the capsules were distributed. 
Appendix 1. Studies from the 1970s
Using community health volunteers in Nepal***
The Nepal program uses an organized volunteer network of female community health volunteers to distribute vitamin A capsules over 2 days every 6 months. Minisurveys report high coverage levels of 85% of the target population. The success of the program is partly attributed to the 15 days of training on basic medical treatment, nutrition, and other health issues as well as on provision of the vitamin A capsules. The volunteers are associated with local health centers and are given preferential consideration in the hiring of maternal and child health workers. The incentive of getting a permanent job in the local health clinics makes the volunteer positions attractive, and the involvement of volunteers, in turn, helps to lower the costs of the vitamin A capsule program.
Comparing stand-alone versus piggybacked interventions in the Philippines*
The cost study of the Philippines is unique in its comparison of two interventions, a stand-alone intervention (Micronutrient Days) with a piggy-backed intervention (polio National Immunization Day). The Micronutrient Days cost twice as much as the supplementation campaign combined with the polio National Immunization Day. The vitamin A capsule program was implemented at the level of the health station in the barangay (the smallest administrative unit in the Philippines, representing an average of 2,500 inhabitants). A midwife and four health workers staff each clinic and set up four distribution centers that are managed by volunteers who distribute the vitamin A supplements. In operation since 1993, this program is the oldest reviewed in this study and has reached the largest number of children (approximately 6.5 million). However, volunteer fatigue has caused coverage rates to fall since the program started, from nearly 90% (1993) to 60% (1999). Better incentives for volunteers have been recommended.
Improving cost-effectiveness in Zambia**
The vitamin A capsule program in Zambia is similar to the Philippine program in that it has two components. One program is a stand-alone effort known as the Child Health Week, which includes health interventions such as deworming, immunization, and growth monitoring. The second program is integrated with polio National Immunization Days. Initially vitamin A capsule coverage was low, particularly in remote rural areas with poor physical infrastructure, but this improved after the Child Health Week program was promoted at the national level. The latter has increased awareness of the multiple role of the vitamin A capsule program, leading to a higher coverage among the target population. 
Complementing sugar fortification in Guatemala*
The vitamin A capsule program in Guatemala (1991) (1992) (1993) (1994) was part of a pilot project organized by a private nonprofit organization that was assisting the Ministry of Health to deliver basic health services in two municipalities. Several surveys had indicated that vitamin A deficiency was a problem among children, and thus the pilot program was started to provide vitamin A capsules to supplement the sugar fortification program that was not reaching all rural communities. The program used midwives and traditional birth attendants as well as community-level volunteers and promoters to distribute the capsules among the mainly rural and poor population. Involving local helpers who spoke the indigenous languages was a key factor in the program's success. 
